798P NeoTrio – Optimal neoadjuvant (NAT) sequencing of anti-PD-1 and BRAF targeted therapy (TT) in BRAF mutant stage III melanoma: Results of histopathological analysis
Jorja Braden, Alison J. Potter, Robert V. Rawson, Nurudeen A. Adegoke, Serigne Lo, Jordan W. Conway, Alexander M. Menzies, Matteo S. Carlino, George Au‐Yeung, Robyn P.M. Saw, Andrew J. Spillane, Kerwin F. Shannon, Thomas E. Pennington, Sydney Ch'ng, David Gyorki, Julie R. Howle, James S. Wilmott, Richard A Scolyer, Georgina V. Long, Inês Pires da Silva
Jodi A. McKenzie, T. Davidson, Susmita Reddy Karri, Antony Lomax, E. Sneath, Yu-Cheng Kuo, Nadav Harel, S. Portela, Kai Cao, Grant A. McArthur, George Au‐Yeung, A.M. Menzies, M.S. Carlino, H.A. Tawbi, Shahneen Sandhu, Lavinia Spain
Robert V. Rawson, Chandra Mani Adhikari, Carolien Bierman, Serigne Lo, Elena Shklovskaya, Elisa A. Rozeman, Alexander M. Menzies, Alexander C.J. van Akkooi, Kerwin F. Shannon, Maria Gonzalez, Alexander Guminski, M.T. Tetzlaff, Jonathan R. Stretch, Hanna Eriksson, Johannes V. van Thienen, Michel W.J.M. Wouters, John B.A.G. Haanen, W. Martin C. Klop, Charlotte L. Zuur, Winan J. van Houdt, Omgo E. Nieweg, Sydney Ch’ng,
Maria Gonzalez, Alexander M. Menzies, Robyn P.M. Saw, John F. Thompson, Andrew J. Spillane, Julie R. Howle, Omgo E. Nieweg, Kerwin F. Shannon, Sydney Ch’ng, Jonathan R. Stretch, Matteo S. Carlino, Alexander Guminski, Louise Emmett, Helen Rizos, Richard A Scolyer, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.